Immortalization of human AE pre-leukemia cells by hTERT allows leukemic transformation.
about
Treating Cancer by Targeting Telomeres and Telomerase.KMT2A promotes melanoma cell growth by targeting hTERT signaling pathway.Transgenic expression of human cytokines in immunodeficient mice does not facilitate myeloid expansion of BCR-ABL1 transduced human cord blood cells.A FOXO1-induced oncogenic network defines the AML1-ETO preleukemic program.
P2860
Immortalization of human AE pre-leukemia cells by hTERT allows leukemic transformation.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Immortalization of human AE pre-leukemia cells by hTERT allows leukemic transformation.
@en
Immortalization of human AE pre-leukemia cells by hTERT allows leukemic transformation.
@nl
type
label
Immortalization of human AE pre-leukemia cells by hTERT allows leukemic transformation.
@en
Immortalization of human AE pre-leukemia cells by hTERT allows leukemic transformation.
@nl
prefLabel
Immortalization of human AE pre-leukemia cells by hTERT allows leukemic transformation.
@en
Immortalization of human AE pre-leukemia cells by hTERT allows leukemic transformation.
@nl
P2093
P2860
P356
P1433
P1476
Immortalization of human AE pre-leukemia cells by hTERT allows leukemic transformation.
@en
P2093
James C Mulloy
Junping Wei
Mark Wunderlich
P2860
P304
55939-55950
P356
10.18632/ONCOTARGET.11093
P407
P577
2016-08-05T00:00:00Z